The North America Bowel Management System Market is expected to witness market growth of 2.8% CAGR during the forecast period (2019-2025).
Fecal incontinence (FI), also known as bowel incontinence, poses a significant problem for the effective and comprehensive treatment of acute and critically ill patients in nursing. The symptoms of fecal incontinence can vary from mild skin irritation to more severe conditions including extreme perineal dermatitis, altered water absorption in the intestinal tract, the transmission of infections, and sepsis when expressed as diarrhea. Fecal incontinence can be a major risk factor for Clostridium difficile and Norovirus transmission, which is commonly transmitted via the fecal-oral route. It reflects contamination of HCWs and patients ' heads, as well as contamination in the patient care community. Family and visitors to the patient are also at risk of cross-contamination.
Effective fecal management systems (FMSs) provide for stool containment and diversion, which is either consistent with liquid or semi-liquid. The FMS helps to keep the skin clean, dry, and free from pollutants and moisture that lead to skin breakdown while also avoiding contamination of the healthcare workers' (HCWs) hands and the environment of patient care.
Keeping infectious body waste stored in a closed system during operation and ongoing use greatly minimizes the possible spread of the infection.
Based on Product, the market is segmented into Irrigation Systems, Colostomy Bags, Nerve Modulation Devices and Other Products. Based on End Use, the market is segmented into Home Care and Hospitals and Ambulatory Surgery Centers. Based on Patient Category, the market is segmented into Pediatric and Adult. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Coloplast Group, 3M Company, Medtronic PLC, B. Braun Melsungen AG, Becton, Dickinson and Company, Axonics Modulation Technologies, Inc., ConvaTec Group PLC, Wellspect Healthcare AB (Dentsply Sirona), Consure Medical, and Prosys International Ltd.
Scope of the Study
Market Segmentation:
By Product
By End Use
By Patient Category
By Country
Companies Profiled
Unique Offerings from the Publisher
Fecal incontinence (FI), also known as bowel incontinence, poses a significant problem for the effective and comprehensive treatment of acute and critically ill patients in nursing. The symptoms of fecal incontinence can vary from mild skin irritation to more severe conditions including extreme perineal dermatitis, altered water absorption in the intestinal tract, the transmission of infections, and sepsis when expressed as diarrhea. Fecal incontinence can be a major risk factor for Clostridium difficile and Norovirus transmission, which is commonly transmitted via the fecal-oral route. It reflects contamination of HCWs and patients ' heads, as well as contamination in the patient care community. Family and visitors to the patient are also at risk of cross-contamination.
Effective fecal management systems (FMSs) provide for stool containment and diversion, which is either consistent with liquid or semi-liquid. The FMS helps to keep the skin clean, dry, and free from pollutants and moisture that lead to skin breakdown while also avoiding contamination of the healthcare workers' (HCWs) hands and the environment of patient care.
Keeping infectious body waste stored in a closed system during operation and ongoing use greatly minimizes the possible spread of the infection.
Based on Product, the market is segmented into Irrigation Systems, Colostomy Bags, Nerve Modulation Devices and Other Products. Based on End Use, the market is segmented into Home Care and Hospitals and Ambulatory Surgery Centers. Based on Patient Category, the market is segmented into Pediatric and Adult. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Coloplast Group, 3M Company, Medtronic PLC, B. Braun Melsungen AG, Becton, Dickinson and Company, Axonics Modulation Technologies, Inc., ConvaTec Group PLC, Wellspect Healthcare AB (Dentsply Sirona), Consure Medical, and Prosys International Ltd.
Scope of the Study
Market Segmentation:
By Product
- Irrigation Systems
- Colostomy Bags
- Nerve Modulation Devices
- Other Products
By End Use
- Home Care
- Hospitals and Ambulatory Surgery Centers
By Patient Category
- Pediatric
- Adult
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Coloplast Group
- 3M Company
- Medtronic PLC
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Axonics Modulation Technologies, Inc.
- ConvaTec Group PLC
- Wellspect Healthcare AB (Dentsply Sirona)
- Consure Medical
- Prosys International Ltd.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. North America Bowel Management Systems Market by Product
Chapter 4. North America Bowel Management Systems Market by End Use
Chapter 5. North America Bowel Management Systems Market by Patient Category
Chapter 6. North America Bowel Management Systems Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Coloplast Group
- 3M Company
- Medtronic PLC
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Axonics Modulation Technologies, Inc.
- ConvaTec Group PLC
- Wellspect Healthcare AB (Dentsply Sirona)
- Consure Medical
- Prosys International Ltd.
Methodology
LOADING...
